Search

Author/Creator Qu, Dongfeng

1. Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer. Issue 5 (16th April 2018)

Authors:
Ge, Yang; Weygant, Nathaniel; Qu, Dongfeng; May, Randal; Berry, William L.; Yao, Jiannan; Chandrakesan, Parthasarathy; Zheng, Wei; Zhao, Lichao; Zhao, Karena L.; Drake, Michael; Vega, Kenneth J.; Bronze, Michael S.; Tomasek, James J.; An, Guangyu; Houchen, Courtney W.
Journal:
International journal of cancer
Issue:
Volume 143:Issue 5(2018)
Page Start:
1162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer. (5th August 2019)

Authors:
Qu, Dongfeng; Weygant, Nathaniel; Yao, Jiannan; Chandrakesan, Parthasarathy; Berry, William L.; May, Randal; Pitts, Kamille; Husain, Sanam; Lightfoot, Stan; Li, Min; Wang, Timothy C.; An, Guangyu; Clendenin, Cynthia; Stanger, Ben Z.; Houchen, Courtney W.
Other Names:
De Felice Francesca Academic Editor.
Journal:
Journal of oncology
Issue:
Volume 2019(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Reverse engineering a predictive signature characterized by proliferation, DNA damage, and immune escape from stage I lung adenocarcinoma recurrence. (12th May 2020)

Authors:
Yao, Jiannan; Xue, Xinying; Qu, Dongfeng; Westphalen, C Benedikt; Ge, Yang; Zhang, Liyang; Li, Manyu; Gao, Tianbo; Chandrakesan, Parthasarathy; Vega, Kenneth J; Peng, Jun; An, Guangyu; Weygant, Nathaniel
Journal:
Acta biochimica et biophysica Sinica
Issue:
Volume 52:Number 6(2020)
Page Start:
638
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗